Coverart for item
The Resource New vistas in therapeutics : from drug design to gene therapy, edited by Sonia I. Skarlatos, Paul Velletri, and Mariana Morris. Drug-resistant tuberculosis : from molecules to macro-economics / edited by Peter Davies

New vistas in therapeutics : from drug design to gene therapy, edited by Sonia I. Skarlatos, Paul Velletri, and Mariana Morris. Drug-resistant tuberculosis : from molecules to macro-economics / edited by Peter Davies

Label
New vistas in therapeutics : from drug design to gene therapy
Title
New vistas in therapeutics
Title remainder
from drug design to gene therapy
Statement of responsibility
edited by Sonia I. Skarlatos, Paul Velletri, and Mariana Morris. Drug-resistant tuberculosis : from molecules to macro-economics / edited by Peter Davies
Title variation
Drug resistant tuberculosis
Title variation remainder
from molecules to macro-economics
Contributor
Subject
Genre
Language
eng
Member of
Additional physical form
Also issued on the Internet.
Cataloging source
EXU
Illustrations
illustrations
Index
index present
Literary form
non fiction
Nature of contents
bibliography
http://library.link/vocab/relatedWorkOrContributorDate
1947-
http://library.link/vocab/relatedWorkOrContributorName
  • Skarlatos, Sonia I
  • Velletri, Paul August
  • Morris, Mariana
  • Davies, P. D. O
  • New York Academy of Sciences
Series statement
Annals of the New York Academy of Sciences,
Series volume
v. 953
http://library.link/vocab/subjectName
  • Therapeutics
  • Drugs
  • Gene therapy
  • Tuberculosis
  • Drug resistance
  • Biological Therapy
  • Drug Therapy
  • Health Policy
  • Tuberculosis, Multidrug-Resistant
  • Tuberculosis, Multidrug-Resistant
Label
New vistas in therapeutics : from drug design to gene therapy, edited by Sonia I. Skarlatos, Paul Velletri, and Mariana Morris. Drug-resistant tuberculosis : from molecules to macro-economics / edited by Peter Davies
Instantiates
Publication
Note
"This volume is the result of two conferences: New Vistas in Therapeutics: From Drug Design to Gene Therapy, ... held as a FASEB satellite meeting on June 3-4, 2000 in Boston, Massachusetts; and Tuberculous Drug Resistance: From Molecules to Macro-Economics, ... held on March 29-30, 2001 in London."--Contents p
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
New vistas in therapeutics: from drug design to gene therapy -- Introduction -- Medicinals for the millennia: the historical record -- Gene therapy: a brief overview of the past, present, and future -- Gene therapy for cardiovascular disorders: is there a future -- Retroviral approaches to gene therapy of cystic fibrosis -- Regulated gene expression in gene therapy -- AAV-mediated gene transfer for hemophilia -- Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair -- Drug-resistant tuberculosis: from molecules to macro-economics -- Scale of the problem -- Burden of drug-resistant tuberculosis and mechanisms for its control -- India's multidrug-resistant tuberculosis crisis -- Drug-resistant tuberculosis in Africa -- Problems in prisons worldwide, with a particular focus on Russia -- Impact of worldwide drug resistance on the United Kingdom -- Specific features of the spread of tuberculosis in Russia at the end of the 20th century -- Tuberculosis in Russia and the problem of multiple drug resistance -- Scientific basis of drug-resistant tuberculosis -- Molecular techniques in the diagnosis of mycobacterium tuberculosis and the detection of drug resistance -- Letting the genome out of the bottle: prospects for new drug development -- Genetics of host resistance and susceptibility to tuberculosis -- Pharmacological issues in the treatment of tuberculosis -- Clinical aspects of drug resistance -- DOTS and DOTS-Plus: not the only answer -- Practicalities of prevention -- Clinical management of the drug-resistant patient -- Multidrug-resistant tuberculosis and HIV infection -- Holding the patient -- Coercion or commitment: policies of prevention -- Moral problems in the use of coercion in dealing with nonadherence in the diagnosis and treatment of tuberculosis -- Just coercion: detention of nonadherent tuberculosis patients -- Missed opportunities coercion or commitment: policies of prevention -- Future -- Multidrug-resistant tuberculosis: this is the cost -- Drug-resistant tuberculosis: concluding remarks
Control code
48934794
Dimensions
24 cm
Dimensions
unknown
Extent
253 pages
Isbn
9781573313353
Isbn Type
(cloth : alk. paper)
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations
Specific material designation
remote
Label
New vistas in therapeutics : from drug design to gene therapy, edited by Sonia I. Skarlatos, Paul Velletri, and Mariana Morris. Drug-resistant tuberculosis : from molecules to macro-economics / edited by Peter Davies
Publication
Note
"This volume is the result of two conferences: New Vistas in Therapeutics: From Drug Design to Gene Therapy, ... held as a FASEB satellite meeting on June 3-4, 2000 in Boston, Massachusetts; and Tuberculous Drug Resistance: From Molecules to Macro-Economics, ... held on March 29-30, 2001 in London."--Contents p
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
New vistas in therapeutics: from drug design to gene therapy -- Introduction -- Medicinals for the millennia: the historical record -- Gene therapy: a brief overview of the past, present, and future -- Gene therapy for cardiovascular disorders: is there a future -- Retroviral approaches to gene therapy of cystic fibrosis -- Regulated gene expression in gene therapy -- AAV-mediated gene transfer for hemophilia -- Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair -- Drug-resistant tuberculosis: from molecules to macro-economics -- Scale of the problem -- Burden of drug-resistant tuberculosis and mechanisms for its control -- India's multidrug-resistant tuberculosis crisis -- Drug-resistant tuberculosis in Africa -- Problems in prisons worldwide, with a particular focus on Russia -- Impact of worldwide drug resistance on the United Kingdom -- Specific features of the spread of tuberculosis in Russia at the end of the 20th century -- Tuberculosis in Russia and the problem of multiple drug resistance -- Scientific basis of drug-resistant tuberculosis -- Molecular techniques in the diagnosis of mycobacterium tuberculosis and the detection of drug resistance -- Letting the genome out of the bottle: prospects for new drug development -- Genetics of host resistance and susceptibility to tuberculosis -- Pharmacological issues in the treatment of tuberculosis -- Clinical aspects of drug resistance -- DOTS and DOTS-Plus: not the only answer -- Practicalities of prevention -- Clinical management of the drug-resistant patient -- Multidrug-resistant tuberculosis and HIV infection -- Holding the patient -- Coercion or commitment: policies of prevention -- Moral problems in the use of coercion in dealing with nonadherence in the diagnosis and treatment of tuberculosis -- Just coercion: detention of nonadherent tuberculosis patients -- Missed opportunities coercion or commitment: policies of prevention -- Future -- Multidrug-resistant tuberculosis: this is the cost -- Drug-resistant tuberculosis: concluding remarks
Control code
48934794
Dimensions
24 cm
Dimensions
unknown
Extent
253 pages
Isbn
9781573313353
Isbn Type
(cloth : alk. paper)
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations
Specific material designation
remote

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...